Pharmacogenomics and personalized medicine /

Saved in:
Bibliographic Details
Imprint:Totowa, NJ : Humana Press, ©2008.
Description:1 online resource (xv, 509 pages) : illustrations
Language:English
Series:Methods in pharmacology and toxicology, 1557-2153
Methods in pharmacology and toxicology.
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11195964
Hidden Bibliographic Details
Other authors / contributors:Cohen, Nadine.
ISBN:9781597454391
1597454397
9781934115046
1934115045
Digital file characteristics:text file PDF
Notes:Includes bibliographical references and index.
English.
Print version record.
Summary:With all of the multitude of challenges facing the pharmaceutical research and development process, the industry is actively exploring the relationships between human genetics and drug responsiveness, susceptibility to disease and disease severity. In Pharmacogenomics and Personalized Medicine, leading experts from the pharmaceutical industry, the scientific community and the government provide guidance for conducting pharmacogenomic research from discovery to the market, while also presenting a realistic perspective on the challenges, practicalities and obstacles in its application. Focusing on DNA data and associated analytical methodologies this volume includes a wide array of vital, cutting-edge research. Comprehensive and timely, Pharmacogenomics and Personalized Medicine will assist novice and experienced investigators alike in the understanding of the current scientific challenges in applying pharmacogenomics to drug discovery and clinical development.
Other form:Print version: Pharmacogenomics and personalized medicine. Totowa, NJ : Humana Press, ©2008 9781934115046
Standard no.:10.1007/978-1-59745-439-1

MARC

LEADER 00000cam a2200000Ia 4500
001 11195964
005 20210625185422.2
006 m o d
007 cr unu||||||||
008 090605s2008 njua ob 001 0 eng d
010 |a  2008925572  |z  2008929439 
015 |a GBA825880  |2 bnb 
016 7 |a 014537708  |2 Uk 
019 |a 771205065  |a 964911218  |a 967622441  |a 990764377  |a 1005781503  |a 1043155771  |a 1058352449  |a 1069477320  |a 1081191040  |a 1087344643  |a 1228587333 
020 |a 9781597454391  |q (e-ISBN) 
020 |a 1597454397  |q (e-ISBN) 
020 |z 9781934115046  |q (hbk. ;  |q alk. paper) 
020 |z 1934115045  |q (hbk. ;  |q alk. paper) 
024 7 |a 10.1007/978-1-59745-439-1  |2 doi 
035 |a (OCoLC)371539067  |z (OCoLC)771205065  |z (OCoLC)964911218  |z (OCoLC)967622441  |z (OCoLC)990764377  |z (OCoLC)1005781503  |z (OCoLC)1043155771  |z (OCoLC)1058352449  |z (OCoLC)1069477320  |z (OCoLC)1081191040  |z (OCoLC)1087344643  |z (OCoLC)1228587333 
035 9 |a (OCLCCM-CC)371539067 
040 |a CUS  |b eng  |e pn  |c CUS  |d CUV  |d GW5XE  |d COO  |d OCLCQ  |d UBY  |d OCLCO  |d OCLCF  |d OCLCO  |d OCLCQ  |d YDXCP  |d EUW  |d OCLCQ  |d OCLCO  |d OCLCQ  |d VT2  |d OCLCA  |d LVT  |d OCLCO  |d LIP  |d MERER  |d OTZ  |d OCLCO  |d OCLCQ  |d STF  |d OCLCO  |d OCLCA  |d BUF  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d CASUM  |d OCLCQ  |d U3W  |d OCLCO  |d AU@  |d OCLCO  |d OCLCA  |d YOU  |d OCLCO  |d UWO  |d OCLCA  |d OCLCQ  |d LND  |d OCLCQ  |d OCLCO  |d U3G  |d OCLCQ  |d OCLCO  |d OCLCQ  |d WURST  |d OCLCA 
049 |a MAIN 
050 4 |a RM301.3.G45  |b P422 2008 
060 4 |a 2008 N-319 
060 4 |a QV 38  |b P53191 2008 
072 7 |a MMG  |2 bicssc 
072 7 |a MED071000  |2 bisacsh 
245 0 0 |a Pharmacogenomics and personalized medicine /  |c Nadine Cohen, editor. 
260 |a Totowa, NJ :  |b Humana Press,  |c ©2008. 
300 |a 1 online resource (xv, 509 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Methods in pharmacology and toxicology,  |x 1557-2153 
505 0 |a Challenges, opportunities, and evolving landscapes in pharmacogenomics and personalized medicine : an industry perspective / Nadine Cohen and Theresa Frangiosa -- Implementation of pharmacogenomic sample collection in clinical trials / Deborah Sokol Ricci and Monique Franc -- Pharmacogenomics : the regulatory environment and labeling implications / Myong-Jin Kim [and others] -- Applications of pharmacogenomics in drug discovery / Duncan McHale -- Applications of pharmacogenomics in clinical trials / Monique Franc -- Pharmacogenomics applications in drug metabolism : from genotyping to drug label-challenges? / Ann K. Daly -- The genetics of adverse drug reactions : promises and problems / Martin Armstrong -- Strategies and resources for marker selection and genotyping in genetic association studies / Nicole Soranzo, Dong-Jing Fu, and Qingqin S. Li -- Study design and statistical issues in pharmacogenetics research : from candidate genes to genome-wide screens / Nicholas J. Schork, Nathalie Malo, and Eric J. Topol -- Holy SNP, Batman! / Reyna Favis -- Predictive biomarker classifiers in the design of pivotal clinical trials / Richard Simon -- Translation of biomarkers into clinical utility / William L. Trepicchio and George Mulligan -- Pharmacogenomic study feasibility assessment and pharmaceutical business decision-making / Monique Franc and Theresa Frangiosa -- Co-development of drugs and pharmacogenomics-based diagnostics in oncology / Jeffrey S. Ross -- Pharmacogenomics applications in epilepsy / Chantal Depondt -- Pharmacogenomics in Alzheimer's disease / Ramón Cacabelos -- Pharmacogenomics applications in psychiatric disorders / Todd Lencz and Anil K. Malhotra -- Pharmacogenomics in HIV disease / Amalio Telenti -- Pharmacogenomics and cardiovascular drugs / Gérard Siest [and others] -- Pharmacogenomic applications in children / Susan F.A. Grant and Hakon Hakonarson -- Pharmacogenomics of rare and monogenic disorders / Paul D. Maher. 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record. 
520 |a With all of the multitude of challenges facing the pharmaceutical research and development process, the industry is actively exploring the relationships between human genetics and drug responsiveness, susceptibility to disease and disease severity. In Pharmacogenomics and Personalized Medicine, leading experts from the pharmaceutical industry, the scientific community and the government provide guidance for conducting pharmacogenomic research from discovery to the market, while also presenting a realistic perspective on the challenges, practicalities and obstacles in its application. Focusing on DNA data and associated analytical methodologies this volume includes a wide array of vital, cutting-edge research. Comprehensive and timely, Pharmacogenomics and Personalized Medicine will assist novice and experienced investigators alike in the understanding of the current scientific challenges in applying pharmacogenomics to drug discovery and clinical development. 
546 |a English. 
650 0 |a Pharmacogenomics.  |0 http://id.loc.gov/authorities/subjects/sh99000126 
650 0 |a Drug development.  |0 http://id.loc.gov/authorities/subjects/sh97007921 
650 1 2 |a Pharmacogenetics. 
650 2 2 |a Drug Design. 
650 7 |a Drug development.  |2 fast  |0 (OCoLC)fst00898670 
650 7 |a Pharmacogenomics.  |2 fast  |0 (OCoLC)fst01060245 
653 0 0 |a farmacologie 
653 0 0 |a pharmacology 
653 0 0 |a genetische variatie 
653 0 0 |a genetic variation 
653 0 0 |a genexpressieanalyse 
653 0 0 |a genomics 
653 0 0 |a individual based models 
653 1 0 |a Pharmacology 
653 1 0 |a Farmacologie 
655 4 |a Electronic books. 
700 1 |a Cohen, Nadine. 
776 0 8 |i Print version:  |t Pharmacogenomics and personalized medicine.  |d Totowa, NJ : Humana Press, ©2008  |z 9781934115046  |w (DLC) 2008925572  |w (OCoLC)213114046 
830 0 |a Methods in pharmacology and toxicology.  |0 http://id.loc.gov/authorities/names/n2001001798 
903 |a HeVa 
929 |a oclccm 
999 f f |i 3cb88d7e-4337-5f39-85b1-fa7cb9c448e3  |s 2a58b2a9-3d14-506f-a4b9-40a519c440f0 
928 |t Library of Congress classification  |a RM301.3.G45 P422 2008  |l Online  |c UC-FullText  |u https://link.springer.com/10.1007/978-1-59745-439-1  |z Springer Nature  |g ebooks  |i 12531240